A double-blinded, randomized, vehicle-controlled study to access skin tolerability and efficacy of an anti-inflammatory moisturizer in treatment of acne with 0.1% adapalene gel

References

• Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49:S1–37
   PubMed Web of Science ®Google Scholar
• Verschoore M, Poncet M, Czernielewski J, et al. Adapalene 0.1% gel has low skin-irrtation potential. J Am Acad Dermatol. 1997;36:S104–9
   Google Scholar
• Cunliffe WJ, Poncet M, Loesche C, et al. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials. Br J Dermatol. 1998;139:48–56
   PubMed Web of Science ®Google Scholar
• Greenspan A, Loesche C, Vendetti N, et al. Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations. Cutis. 2003;72:76–81
   PubMed Web of Science ®Google Scholar
• Brand B, Gilbert R, Baker MD, et al. Cumulative irritancy comparison of adapalene gel 0.1% versus other retinoid products when applied in combination with topical antimicrobial agents. J Am Acad Dermatol. 2003;49:S227–32
   PubMed Web of Science ®Google Scholar
• Dunlap FE, Mills OH, Tuley MR, et al. Adapalene 0.1% gel for the treatment of acne vulgaris: its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference. Br J Dermatol. 1998;139:17–22
   PubMed Web of Science ®Google Scholar
• Caron D, Sorba V, Kerrouche N, et al. Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients. J Am Acad Dermatol. 1997;36:S110–12
   PubMed Web of Science ®Google Scholar
• Angelova-Fischer I, Rippke F, Fischer TW, et al. A double-blind, randomized, vehicle-controlled efficacy assessment study of a skin care formulation for improvement of mild to moderately severe acne. J Eur Acad Dermatol Venereol. 2013;27:6–11
   PubMed Web of Science ®Google Scholar
• Peirano RI, Hamann T, Dusing HJ, et al. Topically applied l-carnitine effectively reduces sebum secretion in human skin. J Cosmet Dermatol. 2012;11:30–6
   PubMed Web of Science ®Google Scholar
• Robinson MK. Racial differences in acute and cumulative skin irriation response between Caucasians and Asian population. Contact Dermatitis. 2000;42:134–43
   PubMed Web of Science ®Google Scholar
• Robinson MK. Population difference in acute skin irritation response, race, sex, age, sensitive skin and repeat subject comparison. Contact Dermatitis. 2002;46:86–93
   PubMed Web of Science ®Google Scholar
• Aramaki J, Kawana S, Effendy I, et al. Difference of skin irritation between Japanese and European women. Br J Dermatol. 2002;146:1052–6
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services, Food and Drug Administration, CDER. Guidance for industry; acne vulgaris: developing drugs for treatment; 2005. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM071292 (accessed 24 Aug 2005)
   Google Scholar
• Pierard GE, Pierard-Franchimont C, Marks R, et al. EEMCO guidance for the in vivo assessment of skin greasiness. The EEMCO Group. Skin Pharmacol Appl Skin Physiol. 2000;13:372–89
   PubMedGoogle Scholar
• Matsunaga K, Leow YH, Chan R, et al. Adjunctive usage of a non-comedogenic moisturizer with adapalene gel 0.1% improves local tolerance: a randomized, investigator-blinded, split-face study in healthy Asian subjects. J Dermatolog Treat. 2013;24:278–82
   PubMed Web of Science ®Google Scholar
• Afzali BM, Yaghoobi E, Yaghoobi R, et al. Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial. J Dermatolog Treat. 2012;23:21–5
   PubMed Web of Science ®Google Scholar
• Thiboutot DM, Weiss J, Bucko A, et al. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol. 2007;57:791–9
   PubMed Web of Science ®Google Scholar
• Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to improve outcomes in acne group. J Am Acad Dermatol. 2009;60:S1–50
   PubMed Web of Science ®Google Scholar
• Zhang JZ, Li LF, Tu YT, et al. A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%. J Dermatolog Treat. 2004;15:372–8
   PubMedGoogle Scholar
• Alirezai M, George SA, Coutts I, et al. Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline. Eur J Dermatol. 2007;17:45–57
   PubMed Web of Science ®Google Scholar
• Feldman SR, Chen DM. How patients experience and manage dryness and irritation from acne treatment. J Drugs Dermatol. 2011;10:605–8
   PubMed Web of Science ®Google Scholar
• Thiboutot D, Pariser DM, Egan N, et al. Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial. J Am Acad Dermatol. 2006;54:242–50
   PubMed Web of Science ®Google Scholar
• Rao GR, Ghosh S, Dhurat R, et al. Efficacy, safety, and tolerability of microsphere adapalene vs. conventional adapalene for acne vulgaris. Int J Dermatol. 2009;48:1360–5
   PubMed Web of Science ®Google Scholar
• Hayashi N, Kawashima M. Study of the usefulness of moisturizers on adherence of acne patients treated with adapalene. J Dermatol. 2014;41:592–7
   PubMed Web of Science ®Google Scholar
• Hatano T, Kagawa H, Yasuhara T, et al. Two new flavonoids and other constituents in licorice root: their relative astringency and radical scavenging effects. Chem Pharm Bull. 1988;36:2090–7
   PubMed Web of Science ®Google Scholar
• Funakoshi-Tago M, Nakamura K, Tsuruya R, et al. The fixed structure of Licochalcone A by alpha, beta-unsaturated ketone is necessary for anti-inflammatory activity through the inhibition of NF-kappaB activation. Int Immunopharmacol. 2010;10:562–71
   PubMed Web of Science ®Google Scholar
• Shibata S, Inoue H, Iwata S, et al. Inhibitory effects of licochalcone A isolated from Glycyrrhiza inflata root on inflammatory ear edema and tumour promotion in mice. Planta Med. 1991;57:221–4
   PubMed Web of Science ®Google Scholar
• Furuhashi I, Iwata S, Shibata S, et al. Inhibition by licochalcone A, a novel flavonoid isolated from liquorice root, of IL-1beta-induced PGE2 production in human skin fibroblasts. J Pharm Pharmacol. 2005;57:1661–6
   PubMed Web of Science ®Google Scholar
• Kolbe L, Immeyer J, Batzer J, et al. Anti-inflammatory efficacy of Licochalcone A: correlation of clinical potency and in vitro effects. Arch Dermatol Res. 2006;298:23–30
   PubMed Web of Science ®Google Scholar
• Wananukul S, Chatproedprai S, Charutragulchai W. Randomized, double-blind, split-side comparison study of moisturizer containing licochalcone vs. 1% hydrocortisone in the treatment of infantile seborrhoeic dermatitis. J Eur Acad Dermatol Venereol. 2012;26:894–7
   PubMed Web of Science ®Google Scholar
• Udompataikul M, Srisatwaja W. Comparative trial of moisturizer containing licochalcone A vs. hydrocortisone lotion in the treatment of childhood atopic dermatitis: a pilot study. J Eur Acad Dermatol Venereol. 2011;25:660–5
   PubMed Web of Science ®Google Scholar
• Lee BJ, Lin JS, Lin YC, et al. Antiinflammatory effects of l-carnitine supplementation (1000 mg/d) in coronary artery disease patients. Nutrition. 2015;31:475–9
   PubMed Web of Science ®Google Scholar
• Edwards C, Marks R. Evaluation of biomechanical properties of human skin. Clin Dermatol. 1995;13:375–80
   PubMed Web of Science ®Google Scholar
• Shimada K, Yoshihara T, Yamamoto M, et al. Transepidermal water loss (TEWL) reflects skin barrier function of dogs. J Vet Med Sci. 2008;70:841–3
   PubMed Web of Science ®Google Scholar